IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) | |
Miles, David; Andre, Fabrice; Gligorov, Joseph; Verma, Sunil; Xu, Binghe; Cameron, David; Barrios, Carlos H.; Schneeweiss, Andreas; Easton, Valerie; Ghazi, Youssef | |
2018 | |
会议名称 | CANCER RESEARCH |
会议日期 | 2018-02-01 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6360438 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Miles, David,Andre, Fabrice,Gligorov, Joseph,et al. IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC)[C]. 见:CANCER RESEARCH. 2018-02-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论